Annalisa Arcari

11PUBLICATIONS
76CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Stochastic analysis and modellingTumour immunologyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 30, 2025
Secondary Genetic Events and Their Relationship to TP53 Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL).

Maria Elena Carazzolo, Francesca Maria Quaglia, Antonino Aparo

|Jun 11, 2025
Copanlisib in combination with rituximab and bendamustine for transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma patients: Results from the phase II multicentre FIL Copa-BR trial from Fondazione Italiana Linfomi (FIL).

Mattia Novo, Pio Manlio Mirko Frascione, Alessia Castellino

|Mar 08, 2025
A phase 2 study of autologous stem cell transplantation as salvage therapy for older patients with aggressive B-cell lymphoma prospectively evaluated by comprehensive geriatric assessment: the FIL_RECANZ study.

Alessandra Tucci, Alessandro Re, Chiara Pagani

|Jan 25, 2025
Retrospective Analysis of R-COMP Therapy in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Assessing the Impact of Sample Selection Bias.

Chiara Romano, Francesco Branda, Nicola Petrosillo

|Oct 26, 2024
Recent Advances in the Molecular Biology of Chronic Lymphocytic Leukemia: How to Define Prognosis and Guide Treatment.

Annalisa Arcari, Lucia Morello, Elena Borotti

|Jul 07, 2023
Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study.

Guido Gini, Monica Tani, Alessandra Tucci

Pageof 2

Frequent Collaborators

4 joint publications

Alessandra Tucci

4 joint publications

Vittorio Ruggero Zilioli

3 joint publications

Donato Mannina

3 joint publications

Luca Arcaini